Market Currents

• Friday, May 22, 2009

• 13:59 PM Johnson & Johnson (JNJ) agrees to buy Cougar Biotechnology (CGRB) for $1B. The move will bolster JNJ's portfolio of oncology drugs. CGRB +16.1%. JNJ +0.4%. 1 Comment
• 09:00 AM Premarket gainers: SHLD +21%. ARUN +19%. AIB +17%. CGRB +15%. EXM +16%. ADSK +15%. ASAY +12%. LEA +10%. FBC +9%. QGEN +8%. CNB +5%. EGLE +5%. KFN +4%. BCS +4%. HEB +4%. AAUK +4%. PBI +4%.
  Losers: RRGB -12%. CRM -9%. LDK -6%. AIG -6%. Comment!